Nikolaos E. Makris

Nikolaos E. Makris

Auto-generated profile, based on publicly available information

Nikolaos E. Makris

Department of Oral Diagnosis and Radiology, School of Dentistry, National and Kapodistrian University of Athens, Athens, Greece

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 June 2013 in European Journal of Nuclear Medicine and Molecular Imaging
Verified
Journal Article
Closed access
PDF file
NMNikolaos E. Makris
Nikolaos E. Makris
MHMarc C. Huisman
Marc C. Huisman
PKPaul E Kinahan
Paul E Kinahan
Adriaan Anthonius LammertsmaAdriaan Anthonius Lammertsma
Adriaan Anthonius Lammertsma
RBRonald Boellaard
Ronald Boellaard

22 January 2015 in Journal of Nuclear Medicine
Verified
Journal Article
Closed access
NMNikolaos E. Makris
Nikolaos E. Makris
RBRonald Boellaard
Ronald Boellaard
ALArthur van Lingen
Arthur van Lingen
Adriaan Anthonius LammertsmaAdriaan Anthonius Lammertsma
Adriaan Anthonius Lammertsma
GDGuus A.M.S. van Dongen
Guus A.M.S. van Dongen
MHMarc C. Huisman
Marc C. Huisman
PET/CT imaging allows for image-based estimates of organ and red marrow (RM) residence times. The aim of this study was to derive PET/CT-based radiation dosimetry for Zr-89-cetuximab, with special emphasis on determining RM-absorbed dose. Methods: Seven patients with colorectal cancer received 36.9 +/- 0.8 MBq of Zr-89-cetuximab within 2 h after administration of a therapeutic dose of 500 mg . m(-2) of cetuximab. Whole-body PET/CT scans and blood samples were obtained at 1, 24, 48, 94, and 144 h after injection. RM activity concentrations were calculated from manual delineation of the lumbar vertebrae and blood samples, assuming a fixed RM-to-plasma activity concentration ratio (RMPR) of 0.19. The cumulated activity was calculated as the area under the curve of the organ time-activity data (liver, lungs, kidneys, spleen, and RM), assuming physical decay after the last scan. The residence time for each organ was derived by dividing the cumulated activity with the total injected activity. The residence time in the remainder of the body was calculated as the maximum possible residence time minus the sum of residence time of source organs, assuming no excretion during the time course of the scans. The (self and total) RM- and organ-absorbed doses and effective whole-body radiation dose were obtained using dose conversion factors from OLINDA/EXM 1.1. Several simplified 3-time-point dosimetry approaches were also evaluated. Results: The first approach yielded self and total RM doses of 0.17 +/- 0.04 and 0.51 +/- 0.06 mGy.MBq(-1), respectively. The second approach deviated by -21% in self-dose and -6% in total dose. RMPR increased over time in 5 of 7 patients. The highest Zr-89-absorbed dose was observed in the liver with 2.60 +/- 0.78 mGy.MBq(-1), followed by the kidneys, spleen, and lungs, whereas the effective whole-body dose was 0.61 +/- 0.09 mSv.MBq(-1). The simplified 3-time-point (1, 48, and 144 h) dosimetry approach deviated by at most 4% in both organ-absorbed doses and effective dose. Conclusion: Although the total RM dose estimates obtained with the 2 approaches differed only by at most 6%, the image-based approach is preferred because it accounts for nonconstant RMPR. The number of successive scans can be reduced to 3 without affecting effective dose estimates.

3 June 2023 in European Journal of Radiology
Verified
Journal Article
Closed access
ZYZafeiroula Yfanti
Zafeiroula Yfanti
STSotirios Tetradis
Sotirios Tetradis
NNNikolaos G. Nikitakis
Nikolaos G. Nikitakis
KAKonstantina Eleni Alexiou
Konstantina Eleni Alexiou
NMNikolaos Makris
Nikolaos Makris
KTKostas Tsiklakis
Kostas Tsiklakis

1 June 2016 in Journal Of Neuroradiology
Verified
Journal Article
Closed access
MTMarianne Theillac
Marianne Theillac
DMDavid Meyronet
David Meyronet
JSJulien Savatovsky
Julien Savatovsky
NMNikolaos Makris
Nikolaos Makris
Salem HannounSalem Hannoun
Salem Hannoun
FCFrancois Cotton
Francois Cotton

22 July 2016 in EJNMMI Physics
Verified
Journal Article
Open access
PDF file
NMN.E. Makris
N.E. Makris
RBR. Boellaard
R. Boellaard
COC. Willemien Menke-van der Houven van Oordt
C. Willemien Menke-van der Houven van Oordt
Adriaan Anthonius LammertsmaAdriaan Anthonius Lammertsma
Adriaan Anthonius Lammertsma
MHM.C. Huisman
M.C. Huisman
The study aims to develop and validate an automatic delineation method for estimating red bone marrow (RM) activity concentration and absorbed dose in 89Zr positron emission tomography/computed tomography (PET/CT) studies. Five patients with advanced colorectal cancer received 37.1 ± 0.9 MBq [89Zr] cetuximab within 2 h after administration of a therapeutic dose of 500 mg m−2 unlabelled cetuximab. Per patient, five PET/CT scans were acquired on a Gemini TF-64 PET/CT scanner at 1, 24, 48, 96 and 144 h post injection. Low dose CT data were used to manually generate volumes of interest (VOI) in the lumbar vertebrae (LV). In addition, LV VOI were generated automatically using an active contour method in a low dose CT. RM activity was then determined by mapping the low dose CT-derived RM VOI onto the corresponding PET scans. Finally, these activities were used to derive residence times and, subsequently, the self and total RM absorbed doses using OLINDA/EXM 1.1. High correlations (r 2 > 0.85) between manual and automated VOI methods were obtained for both RM activity concentrations and total absorbed doses. On average, the automatic method provided values that were lower than 5 % compared to the manual method. An automated and efficient VOI method, based on an active contour approach, was developed, enabling accurate estimates of RM activity concentrations and total absorbed doses.